Synergie SE (SDG)
Euronext Paris · France · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 25.90 |
|---|---|
| 52-week range | 24.60 – 34.10 |
| Return, 1 month / 3 months | −5.1% / −6.5% |
| Return, 1 year / 3 years | −16.8% / −9.3% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 21.7% |
| Worst drawdown (1 year) | -25.2% |
| Average daily value traded | 0.08M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Synergie SE is a French human resources company that provides temporary staffing and recruitment services. Through a network of agencies in France and other European countries, it places workers in short-term assignments with client companies and helps employers find permanent staff. The company also offers related services such as training and human resources support. Its customers are businesses across a range of industries that need flexible labour or help with hiring, and it is based in France.
The shares are listed on the Euronext Paris in France under the code SDG, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Synergie SE (SDG) trades on the Euronext Paris in France. It last closed at EUR 25.90 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 261 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.8% and over the last three months it fell 6.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.4% | ||
| From 52-week high | -23.6% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.5% | ||
| 6-month return | -7.8% | ||
| 12-month return, skipping the last month | -12.3% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.2% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.08M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | −5.1% |
| 3 months | −6.5% |
| 6 months | −7.8% |
| 1 year | −16.8% |
| 3 years | −9.3% |
| 5 years | −26.8% |
Signals
| 50-day / 200-day average | 27.19 / 27.97 |
|---|---|
| Golden / death cross (60 days) | Death, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 0.6000 |
| 27 Jun 2025 | EUR 0.5000 |
| 29 Jun 2023 | EUR 0.8000 |
| 29 Jun 2022 | EUR 0.8000 |
| 21 Oct 2021 | EUR 0.7500 |
| 30 Jun 2021 | EUR 0.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.